The cancer-fighting drug manufacturing facility will create 500 new manufacturing jobs and 4,000 construction jobs.
A total of 120 start-ups were shortlisted, and over 40 have exhibited their most innovative and cutting-edge tech solutions”: ...
Regulators are modernizing their expectations, and it's become clear that validation can no longer function as a point-in-time event.
The Centre allocated ₹10,000 crore for the Biopharma SHAKTI initiative in the Union Budget 2026-27. In alignment with this ...
Pharma and life sciences GCCs reduce drug development timelines and costs by leveraging AI and automation, enhancing R&D efficiency.
Telangana accounts for about one-third of India’s pharmaceutical production and nearly one-fifth of the country’s pharmaceutical exports ...
Wave Life Sciences Ltd. (NASDAQ:WVE) is one of the 13 hot stocks to buy with the highest upside potential. On February 5, BofA initiated coverage of Wave Life Sciences Ltd. (NASDAQ:WVE) with a Buy ...
BioAsia 2026 began in Hyderabad with global stakeholders converging to discuss AI-driven life sciences, as Chief Minister A Revanth Reddy highlighted Telangana’s policy initiatives, investments and am ...
Hyderabad: The 23rd edition of BioAsia 2026 commenced on Tuesday in Hyderabad. This milestone event brings together key stakeholders from across the globe, including leaders in biotechnology, ...
NINGBO, ZHEJIANG, CHINA, January 21, 2026 /EINPresswire.com/ -- Ningbo Scientz Biotechnology Co., Ltd., a leading ...
Indian pharma leaders emphasize shifting focus to high-value products and innovation for future growth and capability leadership.
The GXP site feeds into a surge of biomanufacturing activity in the state’s Eastern Region. The region scored $7.1 billion of the state's $10.8 billion in new life sciences investments announced in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results